Ecolab to Buy AkzoNobel’s Chlorine Dioxide Business

Ecolab to Buy AkzoNobel’s Chlorine Dioxide Business

Ecolab acquires AkzoNobel's Purate business, specializing in global antimicrobial water treatment technology. With 2012 revenue of about $23 million, the Purate business provides patented, proprietary chlorine dioxide programs for use in a wide array of water treatment applications.

"Chlorine dioxide is recognized as an excellent antimicrobial agent to control biologic growth primarily in cooling towers and a wide variety of other industrial water treatment applications," said Timothy Mulhere, Ecolab executive vice president and president, Global Water and Process Services. "Purate's patented technologies complement our offerings globally, including our 3D TRASAR technology programs, which help address our customers' needs for clean water within industrial manufacturing and lower total cost of operations."

According to Ecolab, 3D TRASAR technology combines chemistry, remote services and sophisticated monitoring and controls to improve a range of industrial operations to help customers reduce water use, improve energy efficiency and lower total cost of operations.

Source: Nasdaq

Boutique executive search services with best in class global network, contacts and market mastery.

Deeply connected and engaged personal service approach, long-term investment in client community and 25 year history of strong relations with both Multi-National leaders and Private Equity partners.